G. Zbancioc, I.I. Mangalagiu / Tetrahedron 66 (2010) 278–282
281
Table 3
Intensity of fluorescence for 3 and 4 PP derivatives in acetonitrile
Compd.
3a
3b
3c
3d
4a
4b
4c
4d
Solvent
40.86
Intensity of fluorescence
6276.11
6554.21
7510.05
8264.76
5016.82
5269.64
6018.34
6304.55
4. Experimental section
4.1. General procedures
H4); 13C NMR (TMS, CDCl3,
51.69 (CH3 from 7, COOMe), 105.02 (C5), 114.87 (C3), 119.71 (C7),
d, ppm): 51.51 (CH3 from 5, COOMe),
0
0
122.79 (C6), 128.12 (C4), 128.30 (C2 ), 129.34 (C3 ), 131.84 (C4a),
0
0
133.63 (C1 ), 136.65 (C4 ), 151.09 (C2), 159.53 (7-CO), 163.90 (5-CO).
Anal. calcd for C17H13ClN2O4 (344.75): C 59.23, H 3.80, N 8.13;
found: C 59.20, H 3.73, N 8.05.
All the reagents and solvents used were of the best grade
available and were used without further purification. 1H and 13C
NMR spectra were recorded on
spectrometer, downfield from an internal standard, SiMe4 in CDCl3.
Chemical shifts are given in ppm ( -scale), coupling constants (J) in
a Bruker Avance 400 DRX
4.3.2. 7-Ethyl, 5-methyl 2-(4-chlorophenyl)pyrrolo[1,2-b] pyridazine-
5,7-dicarboxylate (3b). White solid, mp 167–168 ꢂC. IR (KBr, cmꢁ1):
3122 (C–H arom.), 2952 (C–H aliph.), 1708, 1672 (C]O est.), 1550,
1521, 1479, 1469 (C]C, C]N), 1242, 1209 (C–O–C), 825 (C–Cl). 1H
d
Hertz. IR spectra were recorded with a Shimadzu Prestige 8400s
FTIR spectrophotometer in KBr. UV–VIS spectra were recorded with
a Schimadzu UV-1800 spectrometer in acetonitrile. The fluores-
cence values were recorded with a Turner BioSystems fluorimeter.
For the microwave (MW) irradiation a monomode reactor (STAR-2,
CHEM corporation, USA, (800 W) was used. Melting points
were determined using an electrothermal apparatus and are
uncorrected. Flash chromatography was performed with Aldrich
230–400 mesh silica gel (eluent: CH2Cl2:CH3OH¼99:1). TLC was
carried out with Merck silica gel 60-F-254 plates.
NMR (TMS, CDCl3,
d
, ppm): 1.45(t, J¼7.2, 3H: CH3–CH2), 3.93 (s, 3H:
CH3 from 5 position), 4.45 (q, J¼7.2, 2H: CH2–CH3), 7.51–7.47 (m,
0
overlapped peaks, 3H: 2H3 , 1H3), 8.00 (s, 1H: H6), 8.04 (dd, J¼8.8,
J¼2.0, 2H: H2 ), 8.64 (d, J¼9.6, 1H: H4); 13C NMR (CDCl3,
d, ppm, J,
0
Hz): 14.43 (CH3–CH2), 51.48 (CH3 from 5, COOMe), 60.60 (CH2),
104.92 (C5), 114.72 (C3), 120.06 (C7), 122.74 (C6), 128.08 (C4), 128.27
0
0
0
0
(C2 ), 129.30 (C3 ), 131.77 (C4a), 133.67 (C1 ), 136.60 (C4 ), 150.98 (C2),
159.16 (7-CO), 163.93 (5-CO). Anal. calcd for C18H15ClN2O4 (358.78):
C 60.26, H 4.21, N 7.81; found: C 60.23, H 4.12, N 7.71.
4.2. General procedure for [3D2] dipolar cycloaddition in the
liquid phase
4.3.3. Dimethyl 2-(4-bromophenyl)pyrrolo[1,2-b]pyridazine-5,7-di-
carboxylate (3c). Yellow solid, mp 220–221 ꢂC. IR (KBr, cmꢁ1): 3124
(C–H arom.), 2947 (C–H aliph.), 1726, 1695 (C]O est.), 1560, 1463,
1434, 1404 (C]C, C]N), 1245, 1193 (C–O–C), 810 (C–Br). 1H NMR
3-(4-Halophenyl)-pyridazinium bromide (5 mmol) and dipo-
larophile (5.5 mmol) were suspended in 50 mL of anhydrous tolu-
ene (under conventional heating) and 10 mL of anhydrous toluene
(under microwave heating). Then, triethylamine (5.5 mmol) was
added. Under conventional conditions, the solution was refluxed
(oil bath) for 2 h. Under microwave heating, the solution was
exposed to microwaves for 5 min. Using MW irradiation, the best
results were obtained using a constant irradiation power (25% from
the full power of the magnetron, 800 W) and varying the temper-
ature (the so-called ‘power control’). The resulting mixture was
filtered hot to remove triethylamine hydrobromide and the clear
solution was evaporated. The crude product was purified by chro-
matography on silica gel with dichloromethane/methanol (99/1) as
eluent.
(CDCl3,
d, ppm, J, Hz): 3.94 (s, 3H: CH3 from 5 position), 3.97 (s, 3H:
CH3 from 7 position), 7.52 (d, J¼9.6, 1H: H3), 7.65 (dd, J¼8.4, J¼2.0,
0
0
2H: H3 ), 7.98 (dd, J¼8.4, J¼2.0, 2H: H2 ), 8.00 (s, 1H: H6), 8.65 (d,
J¼9.6, 1H: H4); 13C NMR (TMS, CDCl3,
d, ppm): 51.54 (CH3 from 5,
COOMe), 51.72 (CH3 from 7, COOMe), 105.06 (C5), 114.83 (C3), 119.73
0
0
(C7), 122.82 (C6), 125.05 (C4 ), 128.16 (C4), 128.55 (C2 ), 131.87 (C4a),
0
0
132.33 (C3 ), 134.12 (C1 ), 151.18 (C2), 159.55 (7-CO), 163.92 (5-CO).
Anal. calcd for C17H13BrN2O4 (389.20): C 52.46, H 3.37, N 7.20;
found: C 52.37, H 3.29, N 7.10.
4.3.4. 7-Ethyl, 5-methyl 2-(4-bromophenyl)pyrrolo[1,2-b] pyr-
idazine-5,7-dicarboxylate (3d). Yellowsolid, mp 163–164 ꢂC. IR (KBr,
cmꢁ1): 3070 (C–H arom.), 2948 (C–H aliph.), 1706, 1674 (C]O est.),
1552, 1517, 1473 (C]C, C]N), 1242, 1203 (C–O–C), 821 (C–Br). 1H
4.3. General procedure for [3D2] dipolar cycloaddition in the
solid phase
NMR (DMSO,
d
, ppm, J, Hz): 1.40(t, J¼6.8, 3H: CH3–CH2), 3.88 (s, 3H:
CH3 from 5 position), 4.38 (q, J¼6.8, 2H: CH2–CH3), 7.77 (dd, J¼8.4,
0
3-(4-Halophenyl)-pyridazinium bromide (2 mmol), dipolar-
ophile (2.1 mmol) and 15 g of mineral support (KF–Al2O3) were
ground in an agate mortar until a fine homogeneous mixture was
obtained. The mixture was heated under conventional conditions
(oil bath) or exposed to microwaves. The mixture was exposed to
microwaves for 15 min. using 20% power of the magnetron. The
activated solid was cooled, then washed four times: three times
with 10 mL of dichloromethane and once with 10 mL of acetone.
The acetone and dichloromethane were then evaporated and the
product was purified by chromatography on silica gel with
dichloromethane/methanol (99/1) as eluent.
J¼2.0, 2H: H3 ), 7.81 (s,1H: H6), 7.91 (d, J¼9.6,1H: H3), 8.09 (dd, J¼8.4,
J¼2.0, 2H: H2 ), 8.58 (d, J¼9.6, 1H: H4); 13C NMR (TMS, DMSO,
d,
0
ppm): 13.90 (CH3–CH2), 51.05 (CH3 from 5, COOMe), 59.93 (CH2),
0
104.00 (C5), 115.42 (C3), 119.29 (C7), 121.48 (C6), 123.96 (C4 ), 127.51
0
0
0
(C4), 128.50 (C2 ), 130.98 (C4a), 131.74 (C3 ), 133.56 (C1 ), 150.27 (C2),
157.85 (7-CO),162.65 (5-CO). Anal. calcd for C18H15BrN2O4 (403.23):
C 53.62, H 3.75, N 6.95; found: C 53.57, H 3.69, N 6.83.
4.3.5. Trimethyl 2-(4-chlorophenyl)pyrrolo[1,2-b]pyridazine-5,6,7-
tricarboxylate (4a). White solid, mp 185–186 ꢂC. IR (KBr, cmꢁ1):
3109 (C–H arom.), 2954 (C–H aliph.), 1743, 1716, 1685 (C]O est.),
1550, 1523, 1488, 1442 (C]C, C]N), 1255, 1209, 1178 (C–O–C), 817
4.3.1. Dimethyl 2-(4-chlorophenyl)pyrrolo[1,2-b]pyridazine-5,7-di-
carboxylate (3a). White solid, mp 225–226 ꢂC. IR (KBr, cmꢁ1): 3112
(C–H arom.), 2950 (C–H aliph.), 1728, 1697 (C]O est.), 1552, 1465,
1406 (C]C, C]N), 1245, 1199 (C–O–C), 810 (C–Cl). 1H NMR (CDCl3,
(C–Cl). 1H NMR (CDCl3,
d, ppm, J, Hz): 3.92 (s, 3H: CH3 from 5
position), 3.96 (s, 3H: CH3 from 7 position), 4.02 (s, 3H: CH3 from 6
0
position), 7.49 (dd, J¼8.4, J¼2.0, 2H: H3 ), 7.57 (d, J¼9.6,1H: H3), 8.02
(dd, J¼8.4, J¼2.0, 2H: H2 ), 8.64 (d, J¼9.6, 1H: H4); 13C NMR (TMS,
0
d, ppm, J, Hz): 3.93 (s, 3H: CH3 from 5 position), 3.97 (s, 3H: CH3
CDCl3, d, ppm): 51.97 (CH3 from 5, COOMe), 52.21 (CH3 from 7,
0
from 7 position), 7.52–7.47 (m, overlapped peaks, 3H: 2H3 , 1H3),
COOMe), 53.05 (CH3 from 6, COOMe),102.85 (C5), 115.99 (C3),117.45
0
0 0
(C6), 128.39 (C2 ), 128.53 (C4), 128.93 (C7), 129.44 (C3 ), 130.63 (C4a),
7.99 (s, 1H: H6), 8.04 (dd, J¼8.8, J¼2.0, 2H: H2 ), 8.64 (d, J¼9.2, 1H: